Cardioprotective Effect of Daidzein Against Isoproterenol-Induced Myocardial Infarction Injury in Rats

doi:10.21203/rs.3.rs-1330581/v1

Download PDF

Research Article

Cardioprotective Effect of Daidzein Against Isoproterenol-Induced Myocardial Infarction Injury in Rats

https://doi.org/10.21203/rs.3.rs-1330581/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Purpose

Daidzein (DZ) is an isoflavone derived from soy plants that has a wide range of nutritional benefits. The cardioprotective effect of DZ on isoproterenol-induced myocardial infarction (MI) injury in rats was investigated in this work.

Methods

DZ (10 and 20 mg/kg) was given to adult male Wistar Albino rats on a daily basis for 6 weeks. After the treatment period, the rats were subcutaneously injected with isoproterenol (ISO) (85 mg/kg) at 24-hour intervals for two days. Myocardial infarct size, aspartate transaminase (AST), alanine transaminase (ALT), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH) activities, as well as malondialdehyde (MDA) levels, superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione (GSH) catalase (CAT) activities, and the histological alterations in the heart were observed using haematoxylin and eosin staining. Tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels in heart tissues were detected with ELISA kits.

Results

In ISO-induced rats, DZ administration reduced myocardial infract area, improved histological abnormalities in the myocardium, and decreased the activities of myocardial injury marker enzymes. Furthermore, DZ effectively reversed ISO-induced lipid peroxidation and antioxidant depletion, as well as considerably lowering cardiac pro-inflammatory cytokine levels in this animal model.

Conclusion

This research shows that DZ reduces ISO-induced myocardial infarction injury and is linked to a reduction in oxidative stress and inflammation.

isoproterenol

myocardial injury

lipid peroxides

inflammation

Myocardial infarction (MI) is a kind of ischemic heart disease in which the heart muscle is characterised by an imbalance of ischemia and necrosis [1, 2]. Despite considerable prognostic improvements over the last decade, acute myocardial infarction remains the most devastating manifestation of coronary artery disease, affecting over 7 million individuals globally and contributing for over 4 million deaths in Europe and Northern Asia each year [3, 4]. The main pathophysiological processes involved in myocardial infarction have been thoroughly defined: oxidative stress and inflammation [5, 6]. Antioxidant treatment appears to have the capacity to reduce ISO-induced myocardial damage [7–9].

When given in significant amounts, the synthetic catecholamine L-isoproterenol (L-ISO) induces cardiac cell death. It's a common paradigm for producing infarct-like myocardial lesions in rats [10]. An improved understanding of the mechanisms involved in MI has motivated the hunt for a drug that might minimise myocardial harm. A drug that protects the myocardium from toxic substances may help to prevent or postpone myocardial infarction. Free radical scavengers (antioxidants) such as -carotene, vitamin C, vitamin E, and selenium, among other nutritional advantages, have high antioxidant effects because free radical generation causes significant injury in MI.

A polyphenol-rich diet has been demonstrated in several studies to help protect against chronic illnesses, particularly those that are inflammatory and create reactive species. Soybeans are recognised to constitute a complete diet since they include proteins, lipids, essential amino acids, and beneficial secondary metabolites such as isoflavones and phenolic compounds. Soybean isoflavones are thought to be responsible for at least some of the health benefits associated with soy consumption.

In epidemiological research, consumption of soybeans and soy products has been shown to lower the incidence of human cancer, osteoporosis, and cardiovascular disease [11–13]. The three isoflavone aglycones genistein, DZ, and glycitein are all found in four glucosidic forms in soybeans and soy meals. DZ has lately been found to offer a number of health advantages [14–17], including chemoprevention of cardiovascular diseases and cancer, as well as the ability to prevent and cure osteoporosis in postmenopausal women with bone loss without the need of oestrogen replacement medication.

As a result, the goal of this investigation was to see if oral DZ medication might protect rats' hearts against oxidative myocardial damage caused by ISO.

Drugs and Chemicals

Sigma Chemical Co. provided the ISO and DZ (St. Louis, MO, USA). Agappe Diagnostics provided the aspartate transaminase (AST), alanine transaminase (ALT), creatine kinase (CK-MB), and lactate dehydrogenase (LDH) kits (Kerala, India). Commercially available kits (Qualigens Diagnostics) were used to test the activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX), as well as reduced glutathione (GSH) and malondialdehyde (MDA) in cardiac tissues (Mumbai, India). R&D Systems provided ELISA kits for tumour tissue necrosis factor (TNF-α) and interleukin-6 (IL-6) research (Minneapolis, MN, USA).

Animals

The JSS College of Pharmacology sold 32 male Wistar-Albino rats weighing between 180 and 200 grammes. The animals were kept under typical laboratory settings, which included a 12 hr light/dark cycle with a temperature of 252°C and a humidity of 50±15%. They were given a week to acclimate to the circumstances of the animal home before the experiment and were given unlimited access to regular laboratory food and water. The experiment followed the rules set out by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), based in New Delhi, India. The Institutional Animal Ethics Committee of JSS College of Pharmacy in Ooty gave its approval to the experimental protocol (Approval No.06, dated,20-06-2019).

Induction of Experimental MI

To produce experimental MI, ISO was dissolved in normal saline and subcutaneously administered into rats (85 mg/ kg) at 24-hour intervals for two days. The ISO dosage was determined based on prior investigations [18, 19] and a pilot trial for fixation.

Experimental Design

Animals were randomly assigned into four groups (each with eight rats) and treated as follows after a one-week acclimatisation period:

Sham: animals received distilled water (2 ml/kg) for 6 weeks, followed by injection with normal saline (1 ml) on the 43^rd and 44^th days.

ISO: animals received distilled water (2 ml/kg) for 6 weeks, followed by injection with ISO (85 mg/kg) on the 43^rd and 44^th days.

DZ10 + ISO: animals were orally pre-treated with DZ (10 mg/kg/ kg) by gastric gavage needle for 6 weeks, followed by injection with ISO (85 mg/kg) on the 43^rd and 44^th days.

DZ20 + ISO: animals were orally pre-treated with DZ (20 mg/kg/ kg) by gastric gavage needle for 6 weeks, followed by injection with ISO (85 mg/kg) on the 43^rd and 44^th days.

Previous investigations [20-22] were used to determine the DZ dosage. Rats were anaesthetized and slaughtered when the animal experiment was completed. The serum was isolated from blood samples using centrifugation. The heart samples were isolated from the surrounding tissues and cleaned twice with ice-cold phosphate buffer saline immediately after blood collection (PBS). To create about 10% w/v homogenates, the samples were homogenised in phosphate buffer (25 mM, pH 7.4). After centrifuging the homogenates at 1700 rpm for 10 minutes, the supernatant was collected and kept at 20°C until biochemical analysis. For histological investigation, some of the heart samples were kept in 10% formalin.

Histopathological Studies

The cardiac apex was kept in 4% paraformaldehyde, processed in ethanol, and embedded in paraffin wax as soon as the blood was collected. The cardiac apex was stained with haematoxylin and eosin (H&E) and examined under a light microscope at a magnification of 100 times (Olympus, Tokyo, Japan).

Evaluation of Lipid Peroxidation and Antioxidant Enzyme Levels

After the experimental treatment, the homogenates of heart tissues were centrifuged at 16,000 rpm for 10 minutes. The supernatant was utilised to test MDA levels, SOD, CAT, and GPX activity, as well as GSH concentrations, using a microplate reader set at 560 and 532 nm, as directed by the manufacturer. The commercially available test kits were provided by Qualigens Diagnostics (Mumbai, India).

Measurement of MI markers in Serum

According to the manufacturer's instructions, commercial kits from Agappe Diagnostics (Kerala, India) were used to test the activities of AST, ALT, CK-MB, and LDH.

Determination of Pro-Inflammatory Cytokines in Heart

According to the manufacturer's instructions, ELISA kits were used to conduct an enzyme immunoassay of tumour tissue necrosis factor (TNF-α) and interleukin-6 (IL-6) in cardiac homogenate (Minneapolis, MN, USA). The colour intensity was measured at 450 nm using a microplate reader, and the cytokines levels were expressed as pg/ml of tissue (Infinite M200 Pro, Tecan, Switzerland).

Statistical Analysis

All data were expressed as mean SD and analysed using one-way ANOVA followed by a post-hoc test to determine the significant difference between groups. The statistical analysis was carried out using GraphPad Prism 8. (GraphPad Software, Inc., San Diego, CA, USA). A p value of 0.05 or less was considered statistically significant in all tests.

Effect of DZ on AST, ALT, CK-MB and LDH Enzyme Activities in ISO induced rats

We looked at the myocardial damage marker activity in heart tissue from all groups to see if DZ may help with ISO-induced myocardial injury. Two subcutaneous injections of ISO substantially increased blood activities of AST, ALT, CK-MB, and LDH in comparison to the sham group (p< 0.05), as shown in Fig. 1. In this animal model, however, DZ treatment significantly reduced serum AST, ALT, CK-BA, and LDH activity (p< 0.05).

Effect of DZ on Histopathological Assessments in Heart in ISO Induced Rats

In compared to the sham group (p< 0.05), ISO caused a substantial infarction region (Fig. 2). The area of myocardial infarction in DZ-treated groups was significantly reduced (p< 0.05) as compared to the model group (Fig. 2). The preventive effect of DZ in ISO-induced myocardial damage was also validated by histological investigation. As seen in (Fig. 3), sham animals had normal histoarchitecture, but ISO rats' heart tissue had visible cardiac muscle fibres with muscle separation and inflammatory cells. DZ greatly reduced these alterations, resulting in hyperplastic muscle fibres with localised hyalinized muscle bundles and the lack of inflammatory cells.

Effect of DZ on Lipid Peroxidation and Oxidative Stress Parameters in ISO Induced Rats

DZ was tested for its effect on ISO-induced lipid peroxidation and oxidative stress in rats. A considerable rise in MDA, a lipid peroxidation by-product, was identified in the ISO group's heart, as seen in Fig. 4. Furthermore, animals administered ISO displayed decreased antioxidant activity, including SOD, CAT, and GPx, as well as lower non-enzymatic antioxidant (GSH) concentrations, when compared to sham rats. DZ, on the other hand, dramatically decreased cardiac MDA levels, enhanced SOD, CAT, and GPx activities, and elevated GSH concentrations in ISO-treated rats (p< 0.05). These results show that ISO injection causes oxidative stress in the heart of rats, which is reduced by DZ therapy.

Effect of DZ on Pro-Inflammatory Cytokines in ISO Induced Rats

Figure 5 depicts the production of pro-inflammatory cytokines such as TNF-α and IL-6 in cardiac tissues. Injection of ISO substantially raised the production levels of pr-inflammatory cytokines in the heart (p< 0.05) as compared to the sham group. In this animal model, DZ treatment decreased ISO-induced increases in cardiac TNF-α and IL- 6 release.

In this study, the cardioprotective activities of DZ against ISO-induced myocardial infarction damage in rats were discovered. DZ therapy reduced myocardial infract area, enhanced myocardial histoarchitecture, and lowered blood levels of myocyte marker enzymes in rats with ISO-induced myocardial injury. In addition, DZ greatly decreased lipid peroxidation and restored the antioxidant increase caused by ISO.

ISO-induced myocardial injury [23, 24] is a synthetic non-selective-adrenergic agonist that has been routinely used to assess the effect of drugs on myocardial infraction. The current work effectively created a rat model of myocardial damage, as demonstrated by drastically elevated blood levels of AST, ALT, CK-MB, and LDH, as well as aberrant cardiac microstructure detected on histological inspection. These findings are in line with previous in vivo studies [25, 26]. Furthermore, as indicated by considerably lower blood levels of myocardial damage indicators and visibly decreased histological alterations, DZ can attenuate ISO-induced myocardial infarction injury.

Myocardial infarction damage and oxidative stress appear to be connected [27]. There has been a change in oxidant and antioxidant metabolism in individuals with acute myocardial infraction [28, 29]. The initial line of defence against oxidative damage in cells is free radical scavenging enzymes including CAT, SOD, and GPx, as well as GSH [30]. MDA levels increased in ISO-treated rat cardiac tissues, but antioxidants including SOD, CAT, GPx, and GSH decreased. As a consequence, oxidative stress may be involved in ISO-induced myocardial infarction damage in rats. DZ treatment, on the other hand, decreased ISO-induced oxidative stress by increasing antioxidant activity and decreasing lipid peroxidation.

The emergence of high inflammatory cytokine levels has long been linked to acute MI [31]. The levels of these cytokines can be used to predict the severity and duration of an acute MI event [32]. As a result, the identification of cytokines in the blood can be utilised to identify acute MI. Inflammatory cytokines overexpression can result in scar tissue or an infarct, both of which can compromise heart function.

DZ appears to lower TNF-α and IL-6 levels in rats treated with ISO thereafter, according to research. ISO treatment causes TNF-α and IL-6 levels to rise in group II animals. In rats with ISO-induced MI, DZ treatment has an anti-inflammatory effect that is dose-dependent.

According to the current study, DZ exhibited a cardioprotective effect in rats by lowering infarct size. TNF-α and IL-6 expression is also reduced, which has an anti-inflammatory effect. There was a decrease in oxidative stress in rats given DZ. Cardioprotective qualities of DZ are thought to be due to a boost in the cellular antioxidant system and a decrease in inflammatory mediators in myocardial cells.

MI, Myocardial Infarction, ISO, Isoproterenol, AST, Aspartate transaminase, ALT, Alanine transaminase, CK-MB, Creatinine kinase myocardial band, LDH, Lactate dehydrogenase, MDA, Malondialdehyde, GPx, Glutathione peroxidase, GSH, Glutathione, CAT, Catalase, SOD, Superoxide dismutase, TNF-α, Tumour necrosis factor alpha, IL, Interleukin, ELISA, Enzyme linked immunoassay, CPCSEA, Committee for the purpose of control and supervision of experiments on animals, DZ, Daidzein

Acknowledgments

We acknowledge the generous research infrastructure and supports from Department of Pharmacology. (DST-FIST, Sponsored) from JSS College of Pharmacy, JSS Academy of Higher Education & Research, Rocklands, Ooty, The Nilgiris, Tamilnadu, India.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Competing Interests

The authors have no relevant financial or non-financial interests to disclose

Authors Contributions

All authors contributed to research conception and design. Material preparation, data collection and analysis were prepared by [Vadivelan Ramachandran], [Vikash Sundaram] and [Tharani M]. The first draft was written by [Vadivelan Ramachandran], reviewed and edited by [Ruchi Tiwari] and [Meenatchisundaram Subramani] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Ethics approval

The experimental methodology followed the requirements of the CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on Animals) and was approved by the JSS College of Pharmacy's IAEC (Institutional Animal Ethics Committee) (Approval No.06, dated,20-06-2019).

Availability of data and materials

The data supporting the findings of the article will be provided by Dr Vadivelan Ramachandran, Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamilnadu, India ([email protected]) on reasonable request.

Eltzschig HK, Eckle T. Ischemia and reperfusion - from mechanism to translation. Nat Med. 2011, https://doi.org/10.1038/nm.2507
Whellan DJ. Heart failure disease management- Implementation and outcomes. Cardiol Rev. 2005, https://doi.org/10.1097/01.crd.0000135765.60824.2f
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014, Epidemiological update. Eur Heart J. 2014, https://doi.org/10.1093/eurheartj/ehu299
Reed GW, Rossi JE , Cannon CP. Acute myocardial infarction. Lancet. 2017, https://doi.org/10.1016/S0140-6736(16)30677-8
Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K ,Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol. 2002, https://doi.org/10.1006/jmcc.2002.1526
Neri M, Fineschi V, Di Paolo M, et al. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol. 2015, https://doi.org/10.2174/15701611113119990003
Kumar M, Kasala ER, Bodduluru LN, Dahiya V, Lahkar M. Baicalein protects isoproterenol induced myocardial ischemic injury in male Wistar rats by mitigating oxidative stress and inflammation. Inflamm Res. 2016, https://doi.org/10.1007/s00011-016-0944-z
Chen M, Wang M, Yang Q, et al. Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats. Int J Mol Med. 2016, https://doi.org/10.3892/ijmm.2016.2571
Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS one. 2012, https://doi.org/10.1371/journal.pone.0048872
Rona G, Chappel CI, Balazs T, Gaudry R. An infarct like myocardial lesion and other toxic manifestations produced by isoproterenol in rats. Arch Pathol. 1959,67(4):443-5.
Messina, MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk-a review of the in-vitro and in-vivo data. Nutr Cancer.1994, https://doi.org/10.1080/01635589409514310
Potter SM, Baum JA, Teng HY, Stillman RJ, Shay NF, Erdman, JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998, https://doi.org/10.1093/ajcn/68.6.1375s
Anthony MS, Clarkson, TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb. 1997, https://doi.org/10.1161/01.atv.17.11.2524
Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr. 1997, https://doi.org/10.1146/annurev.nutr.17.1.353
Bingham SA, Atkinson C, Coward A. Phyto-estrogens: where are we now? Br J Nutr. 1998, https://doi.org/10.1079/bjn19980068
Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999, https://doi.org/10.1093/jn/129.3.758s
Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2007, https://doi.org/ 10.1002/14651858.CD001395.
Khalil MI, Ahmmed IR. Ahmed R, et al. Amelioration of isoproterenol-induced oxidative damage in rat myocardium by Withania somnifera leaf extract. BioMed Res. Int. 2015, https://doi.org/10.1155/2015/624159
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972,18:499–502.
Ma M, Uekawa K, Hasegawa Y, et al. Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation. Brain Res. 2013, https://doi.org/10.1016/j.brainres.2013.04.040
Kumar M, Kasala ER, Bodduluru LN, et al. Animal models of myocardial infarction. Mainstay in clinical translation. Regul Toxicol Pharmacol. 2016, https://doi.org/10.1016/j.yrtph.2016.03.005
Han S, Cai W, Yang X, et al. ROS-mediated NLRP3 inflammasome activity is essential for burn-induced acute lung injury. Mediat Inflamm. 2015, https://doi.org/10.1155/2015/720457
Karthikeyan K, Bai BR, Devaraj SN. Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats. Int J Cardiol. 2007, https://doi.org/10.1155/2015/720457
Abbas AM. Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol linduced myocardial infarction in rats. J Physiol Biochem. 2016, https://doi.org/10.1007/s13105-016-0494-4
Ramírez-Tortosa, MC, Aguilera, CM, CarriónGutierrez, MA, Ramírez-Boscá, A, Gil, A. Curcumin ethanol-aqueous extract inhibits in vitro human LDL lipoperoxidation. In: Sadler, MJ, Saltmarsh, M, (eds), Functional foods: the consumer, the products, and the evidence. Cambridge Publishers (UK): 1998.
Geng ZH, Huang L, Song MB, Song YM. Protective effect of a polysaccharide from Salvia miltiorrhiza on isoproterenol (ISO)-induced myocardial injury in rats. Carbohydr Polym. 2015, https://doi.org/10.1016/j.carbpol.2015.06.086
Hill MF, Singal PK: Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol. 1996,148:291-300.
Madole MB, Bachewar NP and Aiyar CM. Study of oxidants and antioxidants in patients of acute myocardial infarction. Adv Biomed Res. 2015, https://doi.org/10.4103/2277-9175.168608
Patil N, Chavan V, Karnik ND. Antioxidant status in patients with acute myocardial infarction. Indian J Clin Biochem. 2007, https://doi.org/10.1007/bf02912880
Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease. Roles, mechanisms, and therapeutic implications. Pharmacol Ther. 2001, https://doi.org/10.1016/s0163-7258(00)00114-5
Hamzic N, Blomqvist A, Nilsberth C. Immune-induced expression of lipocalin-2 in brain endothelial cells.relationship with interleukin-6, cyclooxygenase-2 and the febrile response. J Neuroendocrinol. 2013, https://doi.org/10.1111/jne.12000
Eilenberg W, Stojkovic S, Piechota-Polanczyk A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg. 2016, https://doi.org/10.1016/j.ejvs.2016.01.009

Download PDF

Version 1

posted

You are reading this latest preprint version

Cardioprotective Effect of Daidzein Against Isoproterenol-Induced Myocardial Infarction Injury in Rats

Status:

Version 1

Abstract

Purpose

Methods

Results

Conclusion

Figures

Introduction

Materials And Methods

Results

Discussion

Conclusion

Abbreviations

Declarations

References

Status:

Version 1